Wednesday, September 11
7:00am CHECK-IN & CONTINENTAL BREAKFAST
8:00 Welcome and Introduction
Phillip Cuculich, MD
SESSION 1 – Learning to Speak the Same Language
8:10-9:10 Living with Ventricular Tachycardia: A Patient-Centered Look at the Natural History and Treatment Options for VT
- 8:10-8:20 My Journey: VT through the eyes of a patient
Patient
Daniel Cooper, MD
Marye Gleva, MD
- 9:00-9:10 Wrap-up / Q&A
Phillip Cuculich, MD with Speaker Panel
9:10-10:20 What Are They Doing in the Basement? A Primer on Radiotherapy
- 9:10-9:30 Physics of radiotherapy
Nels Knutson, MD
- 9:30-9:50 Biology of radiotherapy
Pamela Samson, MD, MPH
- 9:50-10:10 Cardiotoxicity of radiotherapy
Shahed Badiyan, MD
- 10:10-10:20 Wrap-up / Q&A
Cliff Robinson, MD with Speakers
10:20-10:40 COFFEE BREAK (Provided)
10:40-11:50 Preclinical Data Supporting Cardiac SBRT – Known knowns, known unknowns, and unknown unknowns.
- 10:40-11:00 Summary of Preclinical Data with Photons
Oliver Blanck, PhD (UKSH, Kiel, Germany)
- 11:00-11:20 Update on Mayo Preclinical Work: Protons, Photons, and Carbon
Amanda Deisher, PhD (Mayo Clinic, Rochester, MN)
- 11:20-11:30 SNUH Preclinical Work
Ji Hyun Chang, MD, PhD (Seoul National University Hospital, Seoul, Korea)
- 11:30-11:40 WUSTL Preclinical Work:
Stacey Rentschler, MD, PhD
- 11:40-11:50 Wrap-up / Q&A
Stacey Rentschler, MD, PhD with Speakers
11:50-12:00 GROUP PHOTO
12:00-1:15 LUNCH (Provided) – Interview with a patient starting at 12:45.
1:15-1:45 KEYNOTE 1 – Clinical Trials for VT: Lessons Learned
John Sapp, MD (Professor of Medicine, Physiology & Biophysics, Dalhousie University,
Halifax, Nova Scotia, Canada. Lead Investigator, VANISH and VANISH2 trials)
SESSION 2 – Mapping and Treating
1:45-2:35 How Do We Create a Target?
Breakout Speaker – Timm Dickfield, MD, PhD (University of Maryland, Baltimore, MD)
Breakout Speaker – Paul Zei, MD, PhD (Brigham and Womens, Boston, MA)
2:35-3:25 How Do We Treat the Target?
Breakout Speaker – Geoff Hugo, PhD
Breakout Speaker – Paul Keall, PhD (University of Sydney, Sydney, Australia)
3:25-3:40 Wrap-up / Q&A / Catch-up
Phillip Cuculich, MD and Cliff Robinson, MD with speakers
3:40-4:00 COFFEE BREAK (Provided)
SESSION 3 – Clinical Outcomes
4:00-6:00 Clinical experiences to date
- 4:00-4:20 Overview of Global Treatments and Washington University in St. Louis (St. Louis, MO)
Phillip Cuculich, MD
- 4:20-4:40 University Hospital Ostrava (Ostrava, Czech Republic)
Jakub Cvek, PhD
- 4:40-4:50 University of Maryland (Baltimore, MD)
Pranshu Mohindra, MD
- 4:50-5:10 Lausanne University Hospital (CHUV, Lausanne, Switzerland)
Claudia Herrera-Siklody, MD
- 5:10-5:20 University Hospital Zurich (USZ, Zurich, Switzerland)
Nicolaus Andratschke, MD
- 5:20-5:40 Brigham and Women’s Hospital (Boston, MA)
Paul Zei, MD, PhD
- 5:40-6:00 Multi-centre Experience within the NHS (Sheffield, Newcastle, and Middlesbrough, UK)
Matthew Hatton, MB ChB, MSc (Sheffield Teaching Hospital, Sheffield, UK)
Ewen Shepherd, MB ChB (Newcastle Upon Tynes Hospitals, Newcastle Upon Tynes, UK)
Jim Daniel, MSCi Hons, MsC (South Tees Hospital, Middlesbrough, UK)
6:00-6:20 QA / Panel Discussion
Speakers
6:00-7:30 DRINKS/APPETIZERS (Provided) with Optional Tour of Siteman Cancer Center, Department of Radiation Oncology
7:30+ DINNER (On your own)
The Eric P. Newman Education Center is located in St. Louis’ Central West End neighborhood, and is close to a wide variety of excellent restaurants. We encourage attendees to take advantage of the free evening to explore one of the many nearby options!
Thursday, September 12
8:00 CHECK-IN & CONTINENTAL BREAKFAST
9:00 Welcome and Introduction
Cliff Robinson, MD
SESSION 4 – Real Life Targeting and Treating
9:00-10:20 Group Team Hands-On Interactive Cases for Radiation Oncology and Electrophysiology!
- 9:00-10:00 Hand-On Interactive Cases
All attendees
- 10:00-10:20 Wrap-up / Q&A
Phillip Cuculich, MD and Cliff Robinson, MD
10:20-10:40 COFFEE BREAK
10:40-11:10 KEYNOTE 2 – Introducing Novel Therapies into Clinical Practice: Lessons Learned from Lung SBRT
Robert Timmerman, MD (Professor of Radiation Oncology and Neurological Surgery, UT Southwestern, Dallas, TX. Lead Investigator, RTOG 0236 and 0618 Trials)
11:10-11:30 FDA Regulatory Role (please e-mail Ouided.Rouabhi@fda.hhs.gov for copies)
Ouided Raubhi, MS (Cardiac Ablation, Mapping, and Imaging Devices Team, Office of Cardiovascular Devices, U.S. Food and Drug Administration)
SESSION 5 – Working Lunch, Working Groups, and Working Towards Future Clinical Trials
11:30-12:00 PICK UP LUNCH (Provided)
12:00-12:30 Global Registry
Phillip Cuculich, MD with all attendees (interactive)
12:30-2:00 Consortiums, Trials
Matthew Hatton, MB ChB, MSc (Sheffield Teaching Hospital, Sheffield, UK)
Matthew Bates, MB ChB, PhD (South Tees Hospital, South Tees, UK)
Joost Verhoeff, MD, PhD (UMC Utrecht, Utrecht, Netherlands)
- EU – Kiehl, Germany – RAVENTA Trial
Oliver Blanck, PhD (UKSH, Kiel, Germany)
- EU – Czech Republic – STAR-VT Trial, etc.
Radek Neuwirth, MD (Masaryk University, Brno, Czech Republic)
Cliff Robinson, MD
2:00-3:00 Working Groups
Phillip Cuculich, MD and Cliff Robinson, MD with all attendees (interactive)
3:00 SAFE TRAVELS!